MESOBLAST LTD — Capital/Financing Update 2023

Apr 23, 2023

Market Announcement

==> picture [33 x 50] intentionally omitted <==

24 April 2023

==> picture [451 x 5] intentionally omitted <==

Mesoblast Limited (ASX: MSB) – Suspension from Quotation

Description

The securities of Mesoblast Limited (‘MSB’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of MSB, pending the release of an announcement regarding a private placement.

Issued by

Melissa Kostopoulos

Adviser, Listings Compliance

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

24 April 2023 ASX Limited

==> picture [178 x 23] intentionally omitted <==

24 April 2023

Ms Melissa Kostopoulos Adviser, Listings Compliance (Melbourne) ASX Compliance Pty Limited Level 4 Rialto North Tower 525 Collins Street Melbourne VIC 3000

Dear Melissa

Request for voluntary suspension for Mesoblast Limited (ASX: MSB)

Pursuant to ASX Listing Rule 17.2, Mesoblast Limited ACN 109 431 870 (ASX: MSB; NASDAQ: MESO) (the Company ) requests that ASX grant a voluntary suspension in the trading of its securities effective immediately to allow the Company further time to complete the private placement of securities to targeted investors, particularly given the global nature of the placement.

For the purposes of Listing Rule 17.2, the Company provides the following information:

• (a) the voluntary suspension is requested pending an announcement in relation to the matters above;

• (b) the Company requests that the voluntary suspension continues until the earlier of it making an announcement regarding the matters above and the commencement of trading on Wednesday, 26 April 2023; and

• (c) the Company is not aware of any reason why the voluntary suspension should not be granted or of any other information necessary to inform the market about the voluntary suspension.

Yours sincerely

==> picture [59 x 46] intentionally omitted <==

Niva Sivakumar Company Secretary Mesoblast Limited